Fiera Capital (Canada)
DYN icon

Fiera Capital (Canada)’s Dyne Therapeutics DYN Stock Holding History

Fiera Capital (Canada)’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25M Buy
+1,380,620
New +$23.8M 0.09% 173

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Fiera Capital (Canada)'s DYN Position: Q1 2026 in Review

Fiera Capital (Canada) opened a new position in Dyne Therapeutics (DYN) in Q1 2026: 1,380,620 shares worth $25M. The stake represents 0.09% of the portfolio and ranks #173 among its holdings.

227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Fiera Capital (Canada) held 1,380,620 shares of Dyne Therapeutics worth $25M as of Q1 2026.
  • Dyne Therapeutics was a new Fiera Capital (Canada) position in Q1 2026.
  • Dyne Therapeutics made up 0.09% of Fiera Capital (Canada)'s portfolio in Q1 2026, its #173 holding.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2026, filed 12 May 2026.